Tuesday, 21 February 2017

Cognitive Impairment - Pipeline Review, H1 2015: Complete with Comparative Analysis, Therapeutics Assessment by Drug

ResearchMoz added Latest Research Report titled " Cognitive Impairment - Pipeline Review, H1 2015 " to it's Large Report database.

Global Markets Direct’s, ‘Cognitive Impairment Pipeline Review, H1 2015’, provides an overview of the Cognitive Impairment’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Cognitive Impairment, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Cognitive Impairment and special features on late-stage and discontinued projects.

Request for Sample PDF of Premium Research Report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=279917

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Read All Healthcare Market Research Reports @ http://www.researchmoz.us/healthcare-market-reports-56.html

Table of Contents

Table of Contents 2
List of Tables 7
List of Figures 9

Introduction 10
Global Markets Direct Report Coverage 10
Cognitive Impairment Overview 11
Therapeutics Development 12
Pipeline Products for Cognitive Impairment - Overview 12
Pipeline Products for Cognitive Impairment - Comparative Analysis 13
Cognitive Impairment - Therapeutics under Development by Companies 14
Cognitive Impairment - Therapeutics under Investigation by Universities/Institutes 19
Cognitive Impairment - Pipeline Products Glance 20
Late Stage Products 20
Clinical Stage Products 21
Early Stage Products 22
Cognitive Impairment - Products under Development by Companies 23
Cognitive Impairment - Products under Investigation by Universities/Institutes 29
Cognitive Impairment - Companies Involved in Therapeutics Development 30
AbbVie Inc. 30
Addex Therapeutics Ltd 31
AGY Therapeutics, Inc. 32
Amarantus Bioscience Holdings, Inc. 33
AstraZeneca PLC 34
Avineuro Pharmaceuticals, Inc. 35

About ResearchMoz

ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket Ghumare
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG

No comments:

Post a Comment